It is a pharma public limited company based in New Delhi, Delhi, India, established in 2000.
2000 | New Delhi, Delhi, India | ActiveAdips Laboratories Limited, a active public limited company, was established on 10 April 2000 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24239DL2000PLC105152. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.98 M.
Formerly known as Adips Laboratories Private Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Renu Gera (Whole-Time Director), Narinder Singh Sethi (Whole-Time Director), Om Prakash Gera (Whole-Time Director). Past directors included Shivam Arora, Rakesh Jain. It holds no open charges and ₹0.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 503,Vishwadeep Tower, District Centre Janak Puri, New Delhi, Delhi, 110058.
U24239DL2000PLC105152
105152
10 April 2000
₹1.00 M
₹0.98 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Adips Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Renu Gera | Whole-Time Director | 10 Apr 2000 | Current |
| Narinder Singh Sethi | Whole-Time Director | 10 Apr 2000 | Current |
| Om Prakash Gera | Whole-Time Director | 10 Apr 2000 | Current |
| Lokendra Gera | Whole-Time Director | 01 Aug 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 May 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adips Laboratories Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.75% decrease. The company also saw a substantial fall in profitability, with a 16.28% decrease in profit. The company's net worth moved up by a moderate rise of 9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Adips Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2004 | Punajab National Bank | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Adips Laboratories has a workforce of 26 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adips Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adips Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Adips Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Adips Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge registered on 05 Apr 2004 via Charge ID 90050540 with Punajab National Bank was fully satisfied on 14 Oct 2021. was recorded as a recent event.
Progress on A charge with Punajab National Bank of Rs. 0.50 M registered on 05 Apr 2004 with Charge ID 90050540 was modified on 30 Mar 2005. was documented.
Progress on A charge with Punajab National Bank amounted to Rs. 0.50 M with Charge ID 90050540 was registered on 05 Apr 2004. was documented.
Lokendra Gera was appointed as a Whole-time director was appointed as a Whole-time director on 01 Aug 2002 & has been associated with this company since 23 years 4 months . was recorded as a recent event.
The CIN of Adips Laboratories Limited is U24239DL2000PLC105152.
Adips Laboratories Limited is headquartered at 503,Vishwadeep Tower, District Centre Janak Puri, New Delhi, Delhi, 110058.
Adips Laboratories Limited was incorporated on 10 April 2000.
The current directors of Adips Laboratories Limited are
The primary industry of Adips Laboratories Limited is Manufacturing.
Adips Laboratories Limited is unlisted.
The authorized capital of Adips Laboratories Limited is ₹1.00 M, and the paid-up capital is ₹0.98 M.
The compliance status of Adips Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX